US Patent No: 5,948,437

Number of patents in Portfolio can not be more than 2000

Pharmaceutical compositions using thiazepine

1 Status Updates

Stats

ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

The invention relates to sustained release formulations comprising 11-?4-?2-(2-hydroxyethoxy)ethyl!-1-piperazinyl!dibenzo?b,f! ?1,4!thiazepine or a pharmaceutically acceptable salt thereof, to methods of treating psychotic states and hyperactivity utilizing the sustained release formulations and to a process for preparing the sustained release formulations.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
ASTRAZENECA UK LIMITEDLONDON448
SYNGENTA LIMITEDLONDON486

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Addicks, William Joseph Morgantown, WV 1 13
Parikh, Bhavnish Vinod Hockessin, DE 1 13
Timko, Robert Joseph West Chester, PA 2 13

Cited Art

Patent Info (Count) # Cites Year
 
FOREST LABORATORIES, INC. (7)
4,226,849 Sustained release therapeutic compositions 73 1979
4,357,469 Carrier base material for prolonged release therapeutic compositions 38 1981
4,369,172 Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose 210 1981
4,389,393 Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose 206 1982
4,795,327 Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants 31 1984
4,540,566 Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose 64 1984
4,849,229 Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants 27 1988
 
ALZA CORPORATION (1)
4,871,548 Controlled release dosage form comprising different cellulose ethers 64 1987
 
AMERICAN HOME PRODUCTS CORPORATION (1)
4,309,406 Sustained release pharmaceutical compositions 65 1981
 
ASTRA AKTIEBOLAG (1)
5,419,918 Method for the manufacture of a controlled release solid unit dosage form 5 1993
 
HOFFMANN-LA ROCHE INC. (1)
5,393,765 Pharmaceutical compositions with constant erosion volume for zero order controlled release 29 1993
 
MERCK SHARP & DOHME LTD. (1)
4,919,938 Sustained release pharmaceutical compositions in oral dosage form 14 1989
 
TCF BANK SAVINGS FSB N/K/A TCF NATIONAL BANK (1)
5,126,145 Controlled release tablet containing water soluble medicament 96 1990
 
THE DOW CHEMICAL COMPANY (1)
4,734,285 Sustained release compositions 36 1985
 
ZENECA LIMITED (1)
4,879,288 Novel dibenzothiazepine antipsychotic 24 1987
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (2)
4,259,314 Method and composition for the preparation of controlled long-acting pharmaceuticals 107 1979
4,680,323 Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration 33 1983

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
ASTRAZENECA AB (3)
6,599,897 Quetiapine granules 4 2002
7,022,692 Quetiapine granules 0 2003
8,389,510 Crystalline forms 0 2010
 
CEPHALON, INC. (3)
7,297,346 Pharmaceutical formulations of modafinil 1 2002
7,229,644 Pharmaceutical formulations of modafinil 2 2002
8,268,892 Pharmaceutical formulations of modafinil 0 2008
 
CEPTARIS THERAPEUTICS, INC. (2)
7,872,050 Stabilized compositions of volatile alkylating agents and methods of using thereof 0 2006
7,838,564 Stabilized compositions of volatile alkylating agents and methods of using thereof 0 2009
 
HANDA PHARMACEUTICALS, LLC (2)
8,173,637 Stabilized atypical antipsychotic formulation 0 2008
8,003,637 Stabilized atypical antipsychotic formulation 0 2011
 
KYORIN PHARMACEUTICAL CO., LTD. (1)
7,351,429 Oral solid preparation 1 2000
 
REXAL SUNDOWN, INC. (1)
6,358,526 Method of making tablets and tablet compositions produced therefrom 12 2000
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (1)
8,440,223 Sustained release pharmaceutical compositions comprising quetiapine in non-gellable polymers 0 2009